Philip Morreale, DPM
Foot & Ankle Surgery · Cedar Falls, IANPI 1104810928
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,143 of the $8,397 with a category attached, or 61.2%. 25 manufacturers reported payments, led by Wardlow Enterprises at 40.3% of the total. Reporting peaked in 2021 at $2,722 and has fallen 69.2% since, to $838 in 2025.
Across 148 payments — averaging $56.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Wardlow Enterprises$3K
- Stryker$1K
- Johnson & Johnson$733
- AbbVie$631
- Smith+Nephew$552
- Organogenesis Inc.$318
- plus $1K from 19 others
What the payments were for
- Speaking & faculty fees$601%
- Food & beverage$5,14361%
- Education$3,19438%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Wardlow Enterprises | 7 | $3,388 |
| Stryker(2 entities) | 34 | $1,383 |
| Johnson & Johnson | 15 | $733 |
| AbbVie | 21 | $631 |
| Smith+Nephew | 14 | $552 |
| Organogenesis Inc. | 13 | $318 |
| Orthofix Medical, Inc. | 3 | $204 |
| Treace Medical Concepts, Inc. | 7 | $173 |
| Kerecis Limited | 3 | $159 |
| DJO, LLC | 5 | $158 |
| Vertex | 5 | $143 |
| Zimmer Biomet | 2 | $77 |
| Convatec Inc. | 2 | $69 |
| Amgen(2 entities) | 4 | $66 |
| Bone Support Inc. | 1 | $57 |
| Paratek Pharmaceuticals, Inc. | 3 | $52 |
| Boston Scientific | 1 | $48 |
| Next Science LLC | 1 | $48 |
| Medela LLC | 1 | $30 |
| In2bones USA, LLC | 1 | $30 |
| Linvatec Corporation | 1 | $20 |
| Reprise Biomedical, Inc. | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $14 |
| Osiris Therapeutics Inc. | 1 | $14 |
| Bioventus LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$460
- Physio-Stim$184
- AUGMENT INJECTABLE$175
- PROSTEP MICA$163
- PROstep$160
- ORTHOLOC 3DI$132
- TEFLARO$123
- Kerecis GraftGuide$115
How this compares
$8,397 in reported general payments places this provider in the 70th percentile of 112 foot & ankle surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 59 | $500 |
| Methylprednisolone | 79 | $471 |
| Terbinafine Hcl | 13 | $176 |
| Meloxicam | 15 | $91 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $53 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Cedar Falls
- Charles CibulaCedar Falls$38K
- Nicholas SchmerbachCedar Falls$21K
- Michael LeeDes Moines$2.1M
- Phinit PhisitkulSioux City$1.4M
- Sean GrambartDes Moines$590K
- Kelsey MillonigDes Moines$330K
- Gregory FooteWaterloo$35K
- Nathan ShumwayCouncil Bluffs$33K
- Justin RaatzDes Moines$28K
- Tuvi MendelDavenport$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.